PantaRei is pursuing opportunities created by deregulation and convergence in the gas and electric energy industries, beginning with the pipeline transmission segment of the natural gas industry. Our first offering will allow early adopters to improve competitive position and increase profitability through simultaneous management of flexible contracts and complex pipeline networks. Our proprietary drug discovery platform will enable the cost-effective production and screening of orders of magnitude more compounds for both lead identification and optimization. We will thereby be able to find dramatically more specific drugs against a wide range of protein targets. SmartCure is developing medical devices to treat chronic wounds, a frequent complication of common diseasaes such as diabetes.
Chronic wounds are painful, difficult and expensive to treat.
They occur in 4 million patients each year, and this number is expected to grow with the aging population. In addition to soluble growth factors, micro-mechanical forces are necessary for cell proliferation, the driving force of wound healing. In an environment characterized by intense competition, constantly changing technologies, high customer expectations, and reduced availability of capital, telecom carriers need to focus on using their existing assets in an optimal manner. What Sabre did for airlines, Suchar will do for telecom companies.